Ultreia Capital ltd

Industry:

Venture Capital & Private Equity

Description

Ultreia Capital is a Swiss-based Limited Company. We offer tailor-made services for private equity Life Sciences mandates and focus on proactive management, new investments and portfolio optimization. Currently, we are managing more than USD 100M invested in over 35 private_companies around the world for several institutional clients including Lombard Odier Darier Hentsch & Cie and its LODH Immunology Fund, one of the leading investors in the Life Sciences Private Equity arena.

We are also developing new investment vehicles in the Life Sciences sector targeting drug discovery/development companies and focusing on the U.S. and European markets. We intend to take advantage of currently undervalued assets where Ultreia has identified a clear path to improvement and where we can add value beyond capital.